Daniel P. Judge

Daniel P. Judge

Transplant Surgery | Cardiology

2060 Sam Rittenberg Blvd
Charleston, SC 29407

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 231 publications

An Updated Evidence Assessment of the Genetic Causes of Dilated Cardiomyopathy.

An Updated Evidence Assessment of the Genetic Causes of Dilated Cardiomyopathy.

Journal: Circulation

Published: September 08, 2026

Care Models for the Genetic Evaluation of Dilated Cardiomyopathy at Sites of the DCM Consortium.

Care Models for the Genetic Evaluation of Dilated Cardiomyopathy at Sites of the DCM Consortium.

Journal: Circulation. Heart failure

Published: September 02, 2026

Natriuretic Peptide and Transthyretin and Their Relationship With Clinical Outcomes: Results From ATTRIBUTE-CM, a Randomized Controlled Trial.

Natriuretic Peptide and Transthyretin and Their Relationship With Clinical Outcomes: Results From ATTRIBUTE-CM, a Randomized Controlled Trial.

Journal: Journal of the American Heart Association

Published: August 31, 2026

Impact of Cardiomyopathy and Arrhythmia Genetic Testing on Clinical Management Decisions.

Impact of Cardiomyopathy and Arrhythmia Genetic Testing on Clinical Management Decisions.

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2026

Desmoplakin Mutations in Cardiac Fibroblasts Cause TGFβ1-Mediated Pathological Fibrogenesis in Desmoplakin Cardiomyopathy Via Beclin-1 Regulation.

Desmoplakin Mutations in Cardiac Fibroblasts Cause TGFβ1-Mediated Pathological Fibrogenesis in Desmoplakin Cardiomyopathy Via Beclin-1 Regulation.

Journal: Circulation research

Published: August 19, 2026

Effect of acoramidis on risk of death and heart problem-related hospitalizations in people with transthyretin amyloid cardiomyopathy: a plain language summary.

Effect of acoramidis on risk of death and heart problem-related hospitalizations in people with transthyretin amyloid cardiomyopathy: a plain language summary.

Journal: Future cardiology

Published: August 05, 2026

Plain language summary of how acoramidis affects the total number of heart problems over time in people with ATTR-CM: findings from the ATTRibute-CM study.

Plain language summary of how acoramidis affects the total number of heart problems over time in people with ATTR-CM: findings from the ATTRibute-CM study.

Journal: Future cardiology

Published: August 03, 2026

Geographic and Social Equity in Population-Wide Genomic Screening.

Geographic and Social Equity in Population-Wide Genomic Screening.

Journal: JAMA network open

Published: July 13, 2026

Effects of Acoramidis on Kidney Function in Transthyretin Amyloid Cardiomyopathy.

Effects of Acoramidis on Kidney Function in Transthyretin Amyloid Cardiomyopathy.

Journal: Circulation. Heart failure

Published: July 02, 2026

Long-term effects of acoramidis on mortality in variant transthyretin amyloid cardiomyopathy, including p.Val142Ile: findings from the open-label extension of ATTRibute-CM.

Long-term effects of acoramidis on mortality in variant transthyretin amyloid cardiomyopathy, including p.Val142Ile: findings from the open-label extension of ATTRibute-CM.

Journal: European journal of heart failure

Published: June 15, 2026

Efficacy of Acoramidis in Transthyretin Amyloid Cardiomyopathy With and Without Atrial Fibrillation: Results From ATTRibute-CM.

Efficacy of Acoramidis in Transthyretin Amyloid Cardiomyopathy With and Without Atrial Fibrillation: Results From ATTRibute-CM.

Journal: Journal of cardiac failure

Published: May 08, 2026

Efficacy of Acoramidis in Transthyretin Amyloid Cardiomyopathy With and Without Atrial Fibrillation: Results From ATTRibute-CM.

Efficacy of Acoramidis in Transthyretin Amyloid Cardiomyopathy With and Without Atrial Fibrillation: Results From ATTRibute-CM.

Journal: Journal of cardiac failure

Published: May 08, 2026

Showing 1-12 of 231

Last Updated: 09/26/2026